Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis

Marti, Christophe; John, Gregor Raphaël; Konstantinides, Stavros; Combescure, Christophe; Sanchez, Olivier; Lankeit, Mareike; Meyer, Guy; Perrier, Arnaud

doi:10.1093/eurheartj/ehu218

Scientific article

English

Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis

ContributorsMarti, Christophe; John, Gregor Raphaël

; Konstantinides, Stavros; Combescure, Christophe

; Sanchez, Olivier; Lankeit, Mareike; Meyer, Guy; Perrier, Arnaud

Published inEuropean heart journal, vol. 36, no. 10, p. 605-614

Publication date2015

Abstract

Thrombolytic therapy induces faster clot dissolution than anticoagulation in patients with acute pulmonary embolism (PE) but is associated with an increased risk of haemorrhage. We reviewed the risks and benefits of thrombolytic therapy in the management of patients with acute PE.

Affiliation entities

Research groups

Citation (ISO format)

MARTI, Christophe et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. In: European heart journal, 2015, vol. 36, n° 10, p. 605–614. doi: 10.1093/eurheartj/ehu218

Article (Published version)

Identifiers

PID : unige:45634
DOI : 10.1093/eurheartj/ehu218
PMID : 24917641

Journal ISSN0195-668X

620views

0downloads

Creation25/11/2014 16:53:00

First validation25/11/2014 16:53:00

Update14/03/2023 22:43:53

Status update14/03/2023 22:43:53

Last indexation30/10/2024 22:24:42

Archive ouverte UNIGE

Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis

Thrombolytic therapy induces faster clot dissolution than anticoagulation in patients with acute pulmonary embolism (PE) but is associated with an increased risk of haemorrhage. We reviewed the risks and benefits of thrombolytic therapy in the management of patients with acute PE.

Technical informations